Skip to main content
SpringerLink
Log in

The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Prothrombin (F2) 20210G>A [rs1799963 G>A] mutation is a genetic variant which predisposes to inherited thrombophilia. Highest prevalence of this rare mutation has been reported among Caucasian and Mediterranean populations with thrombophilic conditions compared to healthy controls. It is absent or occurs in a very low frequency in both thrombophilic patients and healthy controls of most South Asian populations. A previous study has demonstrated that the mutant allele is absent among Sri Lankan healthy controls. This study was conducted to determine the prevalence of the F2 20210G>A mutation among Sri Lankan patients with thrombo-embolic disorders. F2 20210G>A mutation analysis was carried out on 825 patients. These included 374 with arterial thromboembolic disorders, 303 with venous thromboembolic disorders (VTE) and 148 with pregnancy related complications. Genotyping was done using polymerase chain reaction followed by restriction fragment length polymorphism. The overall prevalence of the individuals detected with the mutation was 0.8 % (7/825) with a mutant allele frequency of 0.4 % (7/1,650), and all were heterozygotes. Further classification according to the types of thrombotic events showed a prevalence of 0.5 % (2/374), 1.3 % (4/303), and 0.7 % (1/148) respectively, in the three groups with arterial thrombosis, VTE and pregnancy complications. The respective mutant allele frequencies in the three different groups were 0.3 % (2/748), 0.7 % (4/606) and 0.3 % (1/296). Although these figures are lower than that of Caucasian and Mediterranean populations, they are relatively higher compared to other South Asian populations. Therefore, the F2 20210G>A mutant allele is not entirely absent among Sri Lankan patients with thrombo-embolic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous thrombosis. New Eng J Med 344:1222–1231

    Article  CAS  PubMed  Google Scholar 

  2. Varga EA, Kujovich JL (2012) Management of inherited thrombophilia: guide for genetics professionals. Clin Genet 81:7–17

    Article  CAS  PubMed  Google Scholar 

  3. McKusick VA, Hamosh A, Kniffin CL, Bocchini CA, O’Neill MJF(1986-2012) Coagulation factor II; F2 OMIM no. 176930. http://www.omim.org/entry/176930?search=prothrombin%20G20210A&highlight=g20210a%20prothrombin#editHistory-shutter. Accessed 18/07/2013.

  4. De Stefanov V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G (2013) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. New Eng J Med 341:801–806

    Article  Google Scholar 

  5. Spronk HM, Govers-Riemslag JW, Cate H (2003) The blood coagulation system as a molecular machine. Bioessays 25:1220–1228

    Article  CAS  PubMed  Google Scholar 

  6. Sachchithananthan M, Stasinopoulos SJ, Wilusz J, Medcalf RL (2005) The relationship between the prothrombin upstream sequence element and the G20210A polymorphism: the influence of a competitive environment for mRNA 30-end formation. Nucleic Acids Res 33:1010–1020

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, Kulozik AE (2001) Increased efficiency of mRNA 30 end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 28:389–392

    Article  CAS  PubMed  Google Scholar 

  8. Carter AM, Sachchithananthan M, Stasinopoulos S, Maurer F, Medcalf RL (2002) Prothrombin G20210A is a bifunctional gene polymorphism. Thromb Haemost 87:846–853

    CAS  PubMed  Google Scholar 

  9. Ceelie H, Spaargaren-van Riel CC, Bertina RM, Vos HL (2004) G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 30-end formation. J Thromb Haemost 2:119–127

    Article  CAS  PubMed  Google Scholar 

  10. Pollak ES, Lam HS, Russell JE (2002) The G20210A mutation does not affect the stability of prothrombin mRNA in vivo. Blood 100:359–362

    Article  CAS  PubMed  Google Scholar 

  11. Jadaon MM (2011) Epidemiology of Prothrombin G20210A mutation in the Mediterranean region. Mediterr J Hematol Infect Dis 3(1):e2011054. doi:10.4084/MJHID.2011.054

    Article  PubMed Central  PubMed  Google Scholar 

  12. Franco RF, Santos SEB, Elion J, Tavella MH, Zago MA (1998) Prevalence of the G20210A polymorphism in the 3′-untranslated region of the Prothrombin gene in different human populations. Acta Haematol 100:9–12

    Article  CAS  PubMed  Google Scholar 

  13. Dissanayake VHW, Weerasekera LY, Gammulla CG, Jayasekara RW (2009) Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population - implications for association study design and clinical genetic testing services. Exp Mol Pathol 87:159–162

    Article  CAS  PubMed  Google Scholar 

  14. Koksal V, Baris I, Ozdal E (2007) Primer-Engineered multiplex PCR-RFLP for detection of MTHFR C677T, Prothrombin G20210A and factor V Leiden mutations. Exp Mol Pathol 83:1–3

    Article  CAS  PubMed  Google Scholar 

  15. Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W (2006) Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism. Clin Lab Haematol 28:111–116

    Article  CAS  PubMed  Google Scholar 

  16. Lu Y, ZhaoY Liu G, Wang X, Liu Z, Chen B, Hui R (2002) Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res 106:7–12

    Article  CAS  PubMed  Google Scholar 

  17. Sakuma M, Shirato K (2003) The epidemiology of acute pulmonary thromboembolism. Nihon Rinsho 61:1706–1712

    PubMed  Google Scholar 

  18. Miyata T, Kawasaki T, Fujimura H, Uchida K, Tsushima M, Kato H (1998) The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals. Blood Coagul Fibrinolysis 9:451–452

    Article  CAS  PubMed  Google Scholar 

  19. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR (1999) Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost 81:733–738

    CAS  PubMed  Google Scholar 

  20. Chang JD, Hur M, Lee SS, Yoo JH, Lee KM (2008) Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population. Clin Orthop Relat Res 466:1041–1046

    Article  PubMed Central  PubMed  Google Scholar 

  21. Kim YH, Kim J (2007) The 2007 John Charnley award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors. Clin Orthop Relat Res 465:33–39

    PubMed  Google Scholar 

  22. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB (1999) Born to clot: the European burden. Br J Haematol 105:564–566

    Article  CAS  PubMed  Google Scholar 

  23. Shen MC, Lin JS, Tsay W (2000) Protein C and protein S deficiencies are the most important risk factors associated with thrombosis in Chinese venous thrombophilic patients in Taiwan. Thromb Res 99:447–452

    Article  CAS  PubMed  Google Scholar 

  24. Lin JS, Shen MC, Tsay W (1998) The mutation at position 20210 in the 3′-untranslated region of the prothrombin gene is extremely rare in Taiwanese Chinese patients with venous thrombophilia. Thromb Haemost 80:343

    CAS  PubMed  Google Scholar 

  25. Newton LJ, Krishnan A, Parapia LA (1999) Born to clot: the European burden. Br J Haematol 107:213

    Article  CAS  PubMed  Google Scholar 

  26. Kumar SI, Kumar A, Srivastava S, Saraswat VA, Aggarwal R (2005) Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: a case-control study. Indian J Gastroenterol 24:211–215

    PubMed  Google Scholar 

  27. Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A, Pathare A, Jijina F, Mohanty D (2001) Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost 7:158–165

    Article  CAS  PubMed  Google Scholar 

  28. Angeline T, Bently H, Hawk AB, Manners RJ, Mokashi HA, Jeyaraj N, Tsongalis GJ (2005) Prevalence of the factor V G1691A and the factor II/prothrombin G20210A gene polymorphisms among Tamilians. Exp Mol Pathol 79:9–13

    Article  CAS  PubMed  Google Scholar 

  29. Garewal G, Das R, Ahluwalia J, Mittal N, Varma S (2003) Prothrombin G20210A is not prevalent in North India. J Thromb Haemost 1:2253–2254

    Article  CAS  PubMed  Google Scholar 

  30. Seligsohn U, Lubetsky A (2001) Genetic susceptibility to venous Thrombosis. New Eng J Med 344:1222–1231

    Article  CAS  PubMed  Google Scholar 

  31. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703

    CAS  PubMed  Google Scholar 

  32. Butenas S, van’t Veer C, Mann KG (1999) “Normal” thrombin generation. Blood 94:2169–2178

    CAS  PubMed  Google Scholar 

  33. Smirnov MD, Safa O, Esmon NL, Esmon CT (1999) Inhibition of activated protein C anticoagulant activity by prothrombin. Blood 94:3839–3846

    CAS  PubMed  Google Scholar 

  34. Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL et al (2001) Combined effect of factor V Leiden and Prothrombin 2021OA on the risk of venous thromboembolism-pooled analysis of 8 case–control studies including 2,310 cases and 3,204 controls. Thiomb Haemost 86:809–816

    CAS  Google Scholar 

  35. Gohil R, Peck G, Sharma P (2009) The genetics of venous thromboembolism: A meta-analysis involving ~1,20,000 cases and 1,80,000 controls. Thromb Haemost 102:360–370

    CAS  PubMed  Google Scholar 

  36. Chinthammitr Y, Vos HL, Rosendaal FR, Doggen CJM (2006) The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population-based case–control study. J Thromb Haemost 4:2587–2592

    Article  CAS  PubMed  Google Scholar 

  37. Corral J, González R, Lozano ML, Rivera J, Heras I, Vicente V (1997) The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 99:304–307

    Article  CAS  PubMed  Google Scholar 

  38. Vicente V, Gonzalez-Conejero R, Rivera J, Corral J (1999) The prothrombin gene variant 20210A in venous and arterial thromboembolism. Haematologica 84:356–362

    CAS  PubMed  Google Scholar 

  39. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL (1997) A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 90:1747–1750

    CAS  PubMed  Google Scholar 

  40. Doggen CJ, Cats VM, Bertina RM, Rosendaal FR (1998) Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 97:1037–1041

    Article  CAS  PubMed  Google Scholar 

  41. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, Cambou J-P, Scarabin P-Y, Bara L, Green F, Cambien F (1996) β fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. Circulation 93:440–449

    Article  CAS  PubMed  Google Scholar 

  42. Iacovello L, Castelnuovo A, Knijff P, D’Orazio A, Amore C, Arboretti R, Kluft C, Donati MB (1998) Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. New Eng J Med 338:79–85

    Article  Google Scholar 

  43. D’Angelo A, Selhub J (1997) Homocysteine and thrombotic disease. Blood 90:1–11

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Human Genetics Unit, Faculty of Medicine, University of Colombo, Kynsey Road, Colombo 8, Sri Lanka

    K. M. D. Gunathilake, U. N. D. Sirisena, P. K. D. Nisansala, H. W. W. Goonasekera, R. W. Jayasekara & V. H. W. Dissanayake

Authors
  1. K. M. D. Gunathilake
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. N. D. Sirisena
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. K. D. Nisansala
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. W. W. Goonasekera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. W. Jayasekara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. H. W. Dissanayake
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. H. W. Dissanayake.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gunathilake, K.M.D., Sirisena, U.N.D., Nisansala, P.K.D. et al. The Prevalence of the Prothrombin (F2) 20210G>A Mutation in a Cohort of Sri Lankan Patients with Thromboembolic Disorders. Indian J Hematol Blood Transfus 31, 356–361 (2015). https://doi.org/10.1007/s12288-014-0452-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-014-0452-7

Keywords

Search

Navigation